🔎 Trials Near Me

Gara Jalqabaatti › Lymphoma T-Cell Dhiyaataa › New York › New York City

Qorannoo klinikaalii Lymphoma T-Cell Dhiyaataa New York City, NY keessatti

Qorannoo 6 Lymphoma T-Cell Dhiyaataa f New York City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Namoota walitti qabaa jiraSadarkaa 1
  • Columbia University, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04234048

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Cancer Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07192471

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 3
  • Icahn School of Medicine at Mount Sinai, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • Weill Cornell Medicine, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06561048

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Cancer Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07195916

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

Namoota walitti qabaa jiraSadarkaa 1/2
  • Research Site, New York
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06137144

Amping up With PemJAK

Namoota walitti qabaa jiraSadarkaa 2
  • Columbia University Irving Medical Center, New York
Umuriin 18 hanga 95 · Saalaa hunda · Haaromfame 16-Mud-2025 · NCT07283822

Qorannoo Lymphoma T-Cell Dhiyaataa magaalota biroo keessatti

Qorannoo biroo New York City keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 07-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.